Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (583)	6/2/1999 5:57:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 1494

Interesting--the following is all that came up for me when I queried recap for diabetic neuropathy (just query for neuropathy and you will get a few more hits, including Regeneron with a couple phase II's for peripheral neuropathies, and a couple of pre-clinical hits from Cambridge Neuroscience, and one for Valentis) Vertex, VX-853 phase II diabetic neuropathy Cephalon/Chiron/Kyowa Hakko Kogyo, Myotrophin phase II diabetic neuropathy Neurobiological Technologies/Merz-Germany, Memantine phase II/III diabetic peripheral neuropathy & post herpetic neuralgia recap.com of course you have to check this stuff against current PR from the companies to know for sure, as has been pointed out, recap is not completly accurate. A keyword search for neuropathy here on SI will get you some hits, embarrassing to see so many of the hits noise from me ;( Here are two posts NOT from me or fans of NTI: techstocks.com techstocks.com